Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamuel Heath Regulatory News (HSM)

Share Price Information for Samuel Heath (HSM)

Share Price is delayed by 15 minutes
Get Live Data
325.00    0.00 (0.00%)
Bid:
310.00
Ask:
340.00
Spread: 30.00 (9.677%)
Market Cap: £8.24m
HSM Live PriceLast checked at - London Stock Exchange

Intraday Samuel Heath Share Chart

Half-year Report

26 Nov 2024 07:00

RNS Number : 5945N
Heath(Samuel) & Sons PLC
26 November 2024
 

SAMUEL HEATH & SONS plc

("Samuel Heath" or "the Company")

 

UNAUDITED HALF-YEAR REPORT

 

Half year ended 30 September 2024

 

CHAIR'S STATEMENT

 

For the half year ended 30 September 2024, sales came in at £7.55m representing a decrease of £260k (3.3%) compared to the six months ended 30 September 2023 which included a final delivery to a large London contract. The order book held up reasonably well despite adverse market conditions in the UK, where market intelligence suggested order volumes were generally down around 20%. However, the October 2024 order intake was significantly below budget (as discussed below).

 

Operating profit was £481k which compares with £465k in the six months to 30 September 2023, a £16k increase despite the £260k sales reduction. The small improvement in margin reflected labour savings and lower utility costs, as well as lower advertising and trade show costs.

 

Cash and cash equivalents at 30 September 2024 increased by £253k to £1.937m, from £1.684m as at 31 March 2024. Working capital reduced by £130k (mainly lower stocks), while plant expenditure of £319k was incurred to support production efficiency and productivity. However, a significant factor was the absence of a contribution to the defined benefit pension scheme (six months to 30 September 2023: £300k).

 

As mentioned in the financial statements for the year to 31 March 2024, the board has agreed with the pension trustees that the company contribution would be reduced to £300k in the year to 31 March 2025. This newly agreed level will be paid in the second half of the current financial year. Also as previously indicated, the trustees were asked to request a formal valuation at 31 March 2024 and this has now been completed. Using conservative assumptions, the report shows a surplus of £572k on an ongoing basis. In addition, the scheme assets have been transferred to a new fiduciary manager and invested such as to match the performance of assets and liabilities, with the intention of being able to buy out the fund in due course (note the scheme currently has a deficit on a 'solvency' basis).

 

Looking to the second half of the year, the Board has concerns about the economic environment and the state of the markets. As already mentioned, the order intake in October 2024 was significantly below budget and compared to previous months. Up until then, we appeared to be gaining some market share, against a background of depressed markets in the UK. Concerns about the UK government's budget, combined with anticipation of the US election result, contributed to a marked slowdown in order intake which has been evident in the market for several months. With both major events now concluded, we are hopeful that projects that have been on hold will now resume, though this may take several months to reach us in the form of confirmed orders.

 

The Company is pleased to report that the Forme Collection, launched 18 months ago, is selling ahead of budget and should continue to do so. This year has seen the introduction of four key new finishes, with Anthracite and Old Brass shown for the first time at the recent Decorex London exhibition to a very positive audience. New finishes, as we have seen with the recent Antique Brass Matt, can be a significant driver of sales.

 

 

 

 

Anthony Buttanshaw

Chair

26 November 2024

 

 

Dividend

As a result of the uncertain trading conditions, the directors recommend the same interim dividend as last year at 4.5p per share (2023: 4.5p). The interim dividend will be paid on 21 March 2025 to shareholders on the register at the close of business on 21 February 2025. The ex-dividend date for this payment is 20 February 2025.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

 

For further information, please contact:

Samuel Heath & Sons Plc

Simon Latham, Company Secretary 0121 766 4200

 

Cairn Financial Advisers LLP

James Caithie / Jo Turner 020 7213 0880

 

 

 

Unaudited Interim Financial Report

For the Half Year ended 30 September 2024

 

CONSOLIDATED INCOME STATEMENT

Half year

Half year

Year

ended 30

ended 30

ended 31

September

September

March

2024

2023

2024

Unaudited

Unaudited

Audited

£'000

£'000

£'000

 

 

 

Revenue

7,548

7,808

15,237

 

Cost of sales

(4,114)

(4,298)

(8,137)

 

Gross profit

3,434

3,510

7,100

 

Selling and distribution costs

(1,886)

(1,956)

(3,973)

Administrative expenses

(1,067)

(1,089)

(2,313)

Other operating income - grants (note 5)

-

-

18

 

Operating profit

481

465

832

 

Finance income

-

 -

64

Finance cost

(42)

(32)

(12)

 

Profit/(loss) before taxation

439

433

884

 

Taxation

(28)

(22)

(116)

 

 

 

Profit for the period

 

411

 

411

 

768

 

 

 

 

Basic and diluted earnings per ordinary share (note 4)

16.2p

16.2p

30.3p

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

Half year ended 30 September

Half year ended 30 September

Year ended 31 March

 

2024

2023

2024

Unaudited

Unaudited

Audited

£'000

£'000

£'000

 

 

 

 

Profit for the period

411

 

411

768

 

 

 

 

 

 

Items that will not be reclassified to profit or loss:

 

 

Actuarial profit on defined benefit pension scheme

332

 

 45

693

Deferred tax on actuarial profit

(82)

 

(11)

(174)

Revaluation of property, plant and equipment

(43)

 

-

-

Deferred tax on revaluation

11

 

-

-

 

 

218

 

34

519

 

 

Total comprehensive income for the period

629

 

445

1,287

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

At 30 September

 

 At 30 September

 

At 31 March

 

 

2024

 

2023

 

2024

 

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

Non-current assets

 

 

 

 

 

Intangible assets

963

 

723

911

Property, plant and equipment

4,728

 

4,951

4,733

Deferred tax assets

-

 

-

-

Retirement benefit scheme (note 6)

941

 

-

767

 

6,632

 

5,674

6,411

 

 

 

Current assets

 

 

Inventories

4,650

 

4,690

4,842

Trade and other receivables

1,749

 

2,448

2,071

Current tax receivable

-

 

-

-

Cash and cash equivalents

1,937

 

1,473

1,684

 

8,336

 

8,611

8,597

 

 

Total assets

14,968

 

14,285

15,008

 

 

 

Current liabilities

 

 

Trade and other payables

(1,548)

 

(1,718)

(1,989)

Right of use lease liabilities

(28)

 

(62)

(60)

Current tax payable

(28)

 

(22)

-

(1,604)

 

(1,802)

(2,049)

 

 

Non-current liabilities

 

 

Right of use liabilities

(19)

 

(24)

(25)

Deferred tax liability

(758)

 

(818)

(759)

Retirement benefit scheme (note 6)

-

 

(195)

-

 

(777)

 

(1,037)

(784)

 

 

Total liabilities

(2,381)

 

(2,839)

(2,833)

Net assets

12,587

 

11,446

12,175

 

 

Equity

 

 

Called up share capital

254

 

254

254

Capital redemption reserve

109

 

109

109

Revaluation reserve

Retained earnings

1,079

11,145

 

1,183

9,900

1,146

10,666

 

 

Equity shareholders' funds

12,587

 

11,446

12,175

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Attributable to owners of the Parent Company

 

 

Share capital

Capital redemption reserve

Revaluation reserve

Retained earnings

Total equity

 

£000

£000

£000

£000

£000

 

 

 

 

 

 

Balance at 31 March 2023

254

109

1,220

9,610

11,193

 

Total transactions with owners

Equity dividends paid

-

-

-

(192)

 (192)

Profit for the period

-

-

-

411

411

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

-

 

(37)

34

 

37

34

 

-

Total comprehensive income for the period

-

-

(37)

482

445

 

 

 

 

 

 

Balance at 30 September 2023

254

109

1,183

9,900

11,446

 

Total transactions with owners

Equity dividends paid

-

-

-

(113)

(113)

Profit for the period

-

-

-

357

357

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

-

 

(37)

485

 

37

485

 

-

Total comprehensive income for the period

-

-

(37)

879

842

 

 

 

 

 

 

Balance at 31 March 2024

254

109

1,146

10,666

12,175

Total transactions with owners

Equity dividends paid

-

-

-

(217)

(217)

Profit for the period

-

-

-

411

411

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

(32)

 

(35)

250

 

35

218

 

-

Total comprehensive income for the period

-

-

(67)

696

629

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 September 2024

254

109

1,079

11,145

12,587

 

 

 

 

 

 

CONSOLIDATED CASH FLOW STATEMENT

 

Half year ended 30 September

Half year ended 30 September

Year ended 31 March

2024

2023

2024

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Cash flow from operating activities

 

 

 

 

Profit for the period before taxation

439

433

884

 

Adjustments for:

 

Depreciation

246

238

535

Amortisation

106

63

154

(Profit)/loss on disposal of property, plant and equipment

(39)

-

1

Net finance costs/(income)

1

(57)

(52)

Defined benefit pension scheme expenses

83

83

38

Contributions to defined benefit pension scheme

-

(300)

(909)

 

Operating cash flow before movements in working capital

836

460

651

 

 

Changes in working capital:

 

Decrease/(increase) in inventories

192

 (303)

(455)

Decrease/(increase)in trade and other receivables

319

(819)

(442)

(Decrease)/increase in trade and other payables

(381)

107

345

 

Cash (used in) / generated from operations

130 

(1,015)

(552)

 

 

Taxation received

-

-

38

 

Net cash from / (used in) operating activities

966

(555)

137

 

 

 

Cash flow from investing activities

 

Payments to acquire property, plant and equipment

(319)

(402)

(476)

Proceeds from the sale of property, plant and equipment

36

-

1

Payments to acquire intangible assets

(150)

(95)

(374)

Net finance income/(costs)

(1)

57

62

 

Net cash outflow from investing activities

(434)

(440)

(787)

 

 

 

 

Cash flow from financing activities

 

Payment for right of use assets

(38)

(33)

(71)

Dividends paid

(217)

(192)

(305)

 

Net cash outflow from financing activities

(255)

(225)

(376)

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

277

(1,220)

(1,026)

 

Effect of exchange rate differences on cash or cash equivalents

(24)

(24)

(7)

Cash and cash equivalents at beginning of period

1,684

2,717

2,717

Cash and cash equivalents at end of period

1,937

1,473

1,684

 

 

 

 

 

NOTES TO THE INTERIM FINANCIAL REPORT

 

 

1. BASIS OF PREPARATION OF INTERIM REPORT

As permitted, IAS34 'Interim Financial Reporting' has not been applied in this interim report. The information for the period ended 30 September 2024 is not audited and does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The statutory accounts for the year ended 31 March 2024 were given an unqualified audit report and did not contain statements under section 498(2) or 498(3) of the Companies Act 2006. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies. The interim accounts for the half year ended 30 September 2023 were also unaudited.

2. ACCOUNTING POLICIES

Basis of accounting

The report has been prepared on a going concern basis in accordance UK-adopted International Accounting Standards.

 

The group has not availed itself of early adoption options in standards and interpretations.

 

The principal accounting policies adopted are as set out in the Annual Report for the year ended 31 March 2024. The valuation of inventories is considered to be the main area in terms of significant accounting estimates and judgements.

The retirement benefit scheme surplus recognised in these interim accounts reflects the estimated change in the surplus at 30 September 2024 from the movements in discount rates and inflation during the six months.

3. DIVIDENDS

 

A final dividend for the financial year 2024 of 8.5625p per share (2023: 7.5625p) was paid during the period.

 

An Interim dividend for the financial year 2025 of 4.5p per share is proposed (2024: 4.5p), payable on 21 March 2025.

4. EARNINGS PER SHARE

The basic and diluted earnings per share are calculated by dividing the relevant profit after taxation of £411,000 (2023: profit £411,000) by the average number of ordinary shares in issue during the period being 2,534,322 (2023: 2,534,322). The number of shares used in the calculation is the same for both basic and diluted earnings.

5. OTHER OPERATING INCOME

Income was received for the financial year 2024 from RTC North in the form of Grant Funding, supporting the Feasibility of Automated Unloading.

Half year ended 30 September

Half year ended 30 September

Year ended 31 March

2024

2023

2024

Unaudited

Unaudited

Audited

£'000

£'000

£'000

 

 

 

 

 

 

RTC North grant income

-

-

18

 

Total other operating income

-

-

18

 

 

Income has been accounted for under the accruals method.

 

 

NOTES TO THE INTERIM FINANCIAL REPORT (cont.)

 

 

 

6. RETIREMENT BENEFIT SCHEME

 

The values used in the Financial Statements are valued using IAS 19, which shows a surplus of £1.255m (shown in the balance sheet as £941k net of deferred tax). However, the Director's support the goal of a Buyout for the Scheme which is likely to result in a premium being paid to the insurance company. This would mean that the Directors do not expect this asset to be realised or ultimately distributable.

Contributions for the year to 31 March 2025 have been agreed at £300,000, which have yet to be paid.

 

 

 

 

Note: 

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not a guarantee of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DDBDBRSDDGSU
Date   Source Headline
28th Feb 20177:00 amRNSDirectorate Change
16th Nov 20168:00 amRNSHalf-year Report
29th Sep 20163:59 pmRNSDirectorate Change
12th Aug 20161:26 pmRNSResult of AGM
11th Aug 201612:22 pmRNSDirectorate Change
13th Jul 20167:00 amRNSFinal Results
7th Jul 20162:32 pmRNSNotice of Results
6th May 20167:00 amRNSChange of Adviser
4th Nov 20157:00 amRNSHalf Yearly Report
28th Oct 20155:20 pmRNSNotice of Results
15th Jul 20157:00 amRNSFinal Results
12th Jun 20151:04 pmRNSNotice of Results
12th Nov 20147:00 amRNSInterim Report
3rd Nov 20141:41 pmRNSNotice of Results
1st Sep 20149:38 amRNSHolding(s) in Company
16th Jul 20147:00 amRNSFinal Results
4th Jul 20142:25 pmRNSNotice of Results
19th Dec 20139:42 amRNSHolding(s) in Company
19th Dec 20139:40 amRNSHolding(s) in Company
6th Nov 20137:00 amRNSInterim Report
31st Oct 201311:18 amRNSNotice of Results
17th Jul 20137:00 amRNSPreliminary Results
11th Jul 20132:56 pmRNSNotice of Results
15th Jan 201312:09 pmRNSDirector/PDMR Shareholding
20th Nov 20127:00 amRNSHalf Yearly Report
9th Nov 20121:30 pmRNSNotice of Results
19th Sep 20121:48 pmRNSDirector/PDMR Shareholding
12th Sep 20121:44 pmRNSHolding(s) in Company
12th Sep 20129:01 amRNSDirector/PDMR Shareholding
20th Jul 201212:45 pmRNSHolding(s) in Company
12th Jul 20127:00 amRNSFinal Results
4th Jul 20128:48 amRNSNotice of Results
3rd Feb 20124:52 pmRNSDirector/PDMR Shareholding
22nd Nov 20117:00 amRNSHalf Yearly Report
15th Nov 201110:34 amRNSAppointment of Director
9th Nov 20114:37 pmRNSNotice of Results
7th Jul 20117:00 amRNSFinal Results
17th Jun 20114:13 pmRNSNotice of Results
4th Jan 20117:00 amRNSChange of Adviser
23rd Nov 20107:00 amRNSHalf Yearly Report
12th Nov 20103:17 pmRNSNotice of Results
3rd Aug 201011:11 amRNSDirector/PDMR Shareholding
2nd Aug 20102:50 pmRNSHolding(s) in Company
8th Jul 20107:00 amRNSDirectorate Change
8th Jul 20107:00 amRNSFinal Results
2nd Jul 20102:02 pmRNSNotice of Results
1st Apr 20103:37 pmRNSHolding(s) in Company
2nd Dec 20091:59 pmRNSRe Interim Report
24th Nov 20097:00 amRNSHalf Yearly Report
16th Nov 200910:24 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.